Seoul Pharma Co., Ltd (KOSDAQ:018680)
South Korea · Delayed Price · Currency is KRW 2,085.00
-190.00 (-8.35%)
At close: Jun 19, 2026
Seoul Pharma Market Cap
Seoul Pharma has a market cap or net worth of 24.31 billion as of June 18, 2026. Its market cap has decreased by -40.34% in one year.
Market Cap
24.31B
Enterprise Value
23.41B
Revenue
51.33B
Ranking
n/a
PE Ratio
33.49
Stock Price
2,085.00
Market Cap Chart
Since March 1, 2001, Seoul Pharma's market cap has increased from 20.00B to 24.31B, an increase of 21.55%. That is a compound annual growth rate of 0.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 24.31B | -32.31% |
| Dec 30, 2025 | 35.91B | -6.95% |
| Dec 30, 2024 | 38.59B | -13.58% |
| Dec 28, 2023 | 44.66B | -23.86% |
| Dec 29, 2022 | 58.65B | -12.36% |
| Dec 30, 2021 | 66.92B | -28.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Korean Drug | 36.99B |
| GeneBioTech Co. ,Ltd | 36.98B |
| Kyung Nam Pharm | 30.31B |
| HLscience | 29.84B |
| Pharmsville | 27.43B |
| Baskhanbio Pharma | 25.93B |
| Daesung Microbiological Labs. | 24.89B |
| Hurum | 23.63B |